Unlocking Barriers to DNA Vaccine Immunogenicity: A Cross Species Analysis of Cytosolic DNA Sensing in Skeletal Muscle Myocytes
Abstract
DNA vaccine technology holds great promise as a platform for developing vaccines against both emerging and established global pathogens. Despite this potential, significant challenges impede the capacity of DNA vaccines to prevent disease in humans. Foremost amongst these, is the gap between remarkable results obtained in pre-clinical mouse models and relatively modest immunogenicity observed in humans. The present work is testing the hypothesis that skeletal muscle myocytes sense cytosolic DNA and elaborate an inflammatory response to DNA vaccines and that species-specific differences in the cytosolic DNA sensing system bring about divergent inflammatory responses inhuman versus mouse skeletal muscle myocytes.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2018
- Accession Number
- AD1060308
Entities
People
- Gerasimos Zaharatos
Organizations
- Jewish General Hospital